Xin Su Ning—A Review of Basic and Clinical Pharmacology Integrated With Traditional Chinese Medicine Antiarrhythmic Theory
Xin Su Ning (XSN) is a patented multicomponent medicine, which was certified in 2005 by the China State Food and Drug Administration to be produced pharmaceutically and to be used clinically. The XSN capsule was developed from an effective formula composed by Prof. Shuwen Ding of Shandong University...
Enregistré dans:
Auteurs principaux: | Xuan Wang, Taiyi Wang, Shuwen Ding, Yu-Ling Ma |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/feb9f78c300248a6bb8fe922109414d4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy and safety of Chinese herbal medicine Wen Xin granules for the treatment of unstable angina pectoris with Yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial
par: Pan-pan Tian, et autres
Publié: (2021) -
Allicin disrupts cardiac Cav1.2 channels via trafficking
par: Dan Han, et autres
Publié: (2019) -
Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway
par: Hua Gong, et autres
Publié: (2019) -
Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
par: Yao Li, et autres
Publié: (2021) -
Clinical Pharmacology: Advances and Applications
Publié: (2010)